Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stable Schizophrenia”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Early research (Phase 1)Study completedNCT00463372
What this trial is testing

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Who this might be right for
SchizophreniaSchizo-affective Disorder
Pfizer 40
Large-scale testing (Phase 3)WithdrawnNCT01234298
What this trial is testing

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Negative Symptoms of Schizophrenia
Shire
Early research (Phase 1)Study completedNCT01592110
What this trial is testing

A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Zogenix, Inc. 40
Large-scale testing (Phase 3)Study completedNCT00843687
What this trial is testing

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Testing effectiveness (Phase 2)Study completedNCT00922272
What this trial is testing

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Who this might be right for
Schizophrenia and Predominant Negative Symptoms
Shire 92
Very early researchStudy completedNCT04592042
What this trial is testing

Intervention to Improve Coping With Negative Emotions in Patients With Psychosis (Feel-Good-Study)

Who this might be right for
Early PsychosisDelusionsEmotional Distress+1 more
Philipps University Marburg 36
Early research (Phase 1)Ended earlyNCT01568203
What this trial is testing

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Who this might be right for
Schizophrenia
Amgen 50
Post-approval studies (Phase 4)Study completedNCT01010776
What this trial is testing

Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone

Who this might be right for
Schizophrenia
Janssen-Cilag Farmaceutica Ltda. 223
Testing effectiveness (Phase 2)Study completedNCT03319953
What this trial is testing

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

Who this might be right for
Stable Schizophrenia
Neurocrine Biosciences 23
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Very early researchLooking for participantsNCT07344948
What this trial is testing

Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia

Who this might be right for
Healthy ParticipantsSchizophrenia Diagnosis
Neurosterix 73
Testing effectiveness (Phase 2)Ended earlyNCT00977522
What this trial is testing

PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 207
Early research (Phase 1)Ended earlyNCT01900522
What this trial is testing

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

Who this might be right for
Schizophrenia
Takeda 76
Large-scale testing (Phase 3)Ended earlyNCT00396214
What this trial is testing

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Who this might be right for
Schizophrenia
Solvay Pharmaceuticals 83
Early research (Phase 1)Study completedNCT00888693
What this trial is testing

A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 81
Post-approval studies (Phase 4)Study completedNCT03978832
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

Who this might be right for
Schizophrenia
Indivior Inc. 69
Testing effectiveness (Phase 2)Study completedNCT00825539
What this trial is testing

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 68
Large-scale testing (Phase 3)Ended earlyNCT01760993
What this trial is testing

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 2
Early research (Phase 1)Study completedNCT01094249
What this trial is testing

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Who this might be right for
SchizophreniaBipolar DisorderPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 9
Not applicableStudy completedNCT00533260
What this trial is testing

A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)

Who this might be right for
Bipolar DisorderSchizophrenia
AstraZeneca 128
Next Page